Activity-dependent neuroprotective protein: A novel gene essential for brain formation

Developmental Brain Research

Volumn 144, Issue 1, 2003, Pages 83-90

  Pinhasov, Albert ^a   Mandel, Shmuel ^a   Torchinsky, Arkady ^a   Giladi, Eliezer ^a   Pittel, Zipora ^a   Goldsweig, Andrew M ^a   Servoss, Stephen J ^b   Brenneman, Douglas E ^b   Gozes, Illana ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Activity dependent neuroprotective protein; Embryo; Gene expression; Knockout; Neural tube; Vasoactive intestinal peptide

Indexed keywords

ACTIVITY DEPENDENT NEUROPROTECTIVE PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; EMBRYO; EMBRYO DEATH; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GENE FUNCTION; GERM LINE; KNOCKOUT MOUSE; MALE; MORPHOGENESIS; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

EID: 0042347559     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(03)00162-7     Document Type: Article

References (30)

1. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., Bassan H., Blat C., Gibney G., Glazner G., Brenneman D.E., Gozes I. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72:1999;1283-1293.
2. Blondel O., Collin C., McCarran W.J., Zhu S., Zamostiano R., Gozes I., Brenneman D.E., McKay R.D. A glia-derived signal regulating neuronal differentiation. J. Neurosci. 20:2000;8012-8020.
3. Brenneman D.E., Eiden L.E. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA. 83:1986;1159-1162.
4. Colas J.-F., Schoenwolf G.C. Towards a cellular and molecular understanding of neurulation. Dev. Dyn. 221:2001;117-145.
5. Fuhrmann G., Chung A.C., Jackson K.J., Hummelke G., Baniahmad A., Sutter J., Sylvester I., Scholer H.R., Cooney A.J. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev. Cell. 1:2001;377-387.
6. Glaser T., Jepeal L., Edwards J.G., Young S.R., Favor J., Maas R.L. PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects. Nature Genet. 7:1994;463-471.
7. Gozes I., Shani Y., Rostene W.H. Developmental expression of the VIP-gene in brain and intestine. Mol. Brain Res. 2:1987;137-148.
8. Gozes I., Schachter P., Shani Y., Giladi E. Vasoactive intestinal peptide gene expression from embryos to aging rats. Neuroendocrinology. 47:1988;27-31.
9. Gozes I., Glowa J., Brenneman D.E., McCune S.K., Lee E., Westphal H. Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene. J. Mol. Neurosci. 4:1993;185-193.
10. Gozes I., Brenneman D.E. A new concept in neuroprotection. J. Mol. Neurosci. 14:2000;61-68.
11. Gozes I., Giladi E., Pinhasov A., Bardea A., Brenneman D.E. Activity-dependent neurotrophic factor: Intranasal administration of femtomolar-acting peptides improve performance in a water maze. J. Pharmacol. Exp. Ther. 293:2000;1091-1098.
12. Gozes I., Zamostiano R., Pinhasov A., Bassan M., Giladi E., Steingart R.A., Brenneman D.E. A novel VIP-responsive gene: activity-dependent neuroprotective protein (ADNP). Ann. NY Acad. Sci. 921:2000;115-118.
13. Gressens P., Hill J.M., Gozes I., Fridkin M., Brenneman D.E. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature. 362:1993;155-158.
14. Gressens P., Hill J.M., Paindaveine B., Gozes I., Fridkin M., Brenneman D.E. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. J. Clin. Invest. 94:1994;2020-2027.
15. Juriloff D.M., Harris M.J. Mouse models for neural tube closure defects. Hum. Mol. Genet. 9:2000;993-1000.
16. Kaufman M.H. The Atlas of Mouse Development. Revised Edition: 1999;Academic Press, San Diego.
17. Leker R.R., Teichner A., Grigoriadis N., Ovadia H., Brenneman D.E., Fridkin M., Giladi E., Romano J., Gozes I. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke. 33:2002;1085-1092.
18. Mukhopadhyay M., Shtrom S., Rodriguez-Esteban C., Chen L., Tsukui T., Gomer L., Dorward D.W., Glinka A., Grinberg A., Huang S.P., Niehrs C., Belmonte J.C., Westphal H. Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev. Cell. 1:2001;423-434.
19. Muzio L., DiBenedetto B., Stoykova A., Boncinelli E., Gruss P., Mallamaci A. Conversion of cerebral cortex into basal ganglia in Emx2(-/-) Pax6(Sey/Sey) double-mutant mice. Nature Neurosci. 5:2002;737-745.
20. Poggi S.H., Vink J., Goodwin K., Hill J.M., Brenneman D.E., Pinhasov A., Gozes I., Spong C.Y. Differential expression of embryonic and maternal activity-dependent neuroprotective protein during mouse development. Am. J. Obstet. Gynecol. 187:2002;973-976.
21. Romano J., Beni-Adani L., Nissenbaum O.L., Brenneman D.E., Shohami E., Gozes I. A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene atlas array analysis. J. Mol. Neurosci. 18:2002;37-45.
22. Servoss S.J., Lee S.J., Gibney G., Gozes I., Brenneman D.E., Hill J.M. IGF-I as a mediator of VIP/activity-dependent neurotrophic factor-stimulated embryonic growth. Endocrinology. 142:2001;3348-3353.
23. Shizuya H., Birren B., Kim U.J., Mancino V., Slepak T., Tachiiri Y., Simon M. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sci. USA. 89:1992;8794-8797.
24. Sigalov E., Fridkin M., Brenneman D.E., Gozes I. VIP-related protection against iodoacetate toxicity in pheochromocytoma (PC12) cells. A model for ischemic/hypoxic injury. J. Mol. Neurosci. 15:2000;147-154.
25. Spong C.Y., Abebe D.T., Gozes I., Brenneman D.E., Hill J.M. Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J. Pharmacol. Exp. Ther. 297:2001;774-779.
26. Tybulewicz V.L., Crawford C.E., Jackson P.K., Bronson R.T., Mulligan R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the C-abl proto-oncogene. Cell. 65:1991;1153-1163.
27. Waltner C., Gruss P. PAX-6 a murine paired box gene, is expressed in developing CNS. Development. 113:1991;1435-1449.
28. Wu J.Y., Henins K.A., Gressens P., Gozes I., Fridkin M., Brenneman D.E., Hill J.M. Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period. Peptides. 18:1997;1131-1137.
29. Zamostiano R., Pinhasov A., Gelber E., Steingart R.A., Seroussi E., Giladi E., Bassan M., Wollman Y., Eyre H.J., Mulley J.C., Brenneman D.E., Gozes I. Cloning and characterization of the human activity-dependent neuroprotective protein. J. Biol. Chem. 276:2001;708-714.
30. Zhao Y., Westphal H. Homeobox genes and human genetic disorders. Curr. Mol. Med. 2:2002;13-23.